Russia invaded Ukraine on 24 of February 2022. Stand with Ukraine and support us in a fight for freedom and democracy in Europe.  Stand with Ukraine!  Join us
Chemotherapy for Brain Tumor
All specialties

Discover the Best Clinics and Costs for Chemotherapy for Brain Tumor in Turkey 2024

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood - General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Discover the Best Clinics and Costs for Chemotherapy for Brain Tumor in Turkey 2024

7 Recent Chemotherapy for Brain Tumor Reviews in Turkey: Check Real Patient Experience

Владислав Потруг • Glioblastoma
Moldova
Sep 10, 2018

Verified review.
The results are excellent
Everything went very well, the attending physician and the medical staff are great fellows and super professionals. Read more less

Виктория • Brain tumor
Ukraine
Aug 7, 2018

Verified review.
I recommend
All very pleased, pleasures people, experienced doctors, friendly staff, I recommend Read more less

Евгения Бедрий • Glioma
Italy
Mar 7, 2019

Verified review.
All liked it. Professionals Read more less

Chemotherapy for Brain Tumor Overview in Turkey

patients recommend -
78%
Surgery Time - 4 hours
Stay in the country - 7 days
Rehabilitation - 30 days
Anesthesia - General anesthesia
Verified patient reviews - 7
Requests processed - 46119
Bookimed fees - $0

How Much Does Chemotherapy for Brain Tumor Cost in Turkey? Find Out Now

updated 5/6/2024
The average price of Chemotherapy for Brain Tumor in Turkey is $2050, the minimum price is $1000, and the maximum price is $3000.
Request the price
United States of America Turkey Mexico
Chemotherapy for Brain Tumor -from $1000 -
The total cost is calculated individually. It may range depending on your medical issue, doctor's qualification, procedure complexity and related complications (if they occur). You’ll get the exact price for a plastic surgery procedure after a consultation with a doctor.
Below average
Above average
According to 8 clinics presented in the ranking
Discover the Best Chemotherapy for Brain Tumor Clinics in Turkey: 8 Verified Options and Prices
Check the hospital ranking based on requests and 7 reviews to pick the right Chemotherapy for Brain Tumor clinic for you.
Turkey, Istanbul
92% patients recommend

Read more details Hide details

Anadolu Medical Center is a multidisciplinary facility providing American treatment standards at affordable prices in Istanbul (Turkey). Anadolu affiliates with the Johns Hopkins Hospital, one of the best medical facilities in the USA.

Oncology, hematology oncology, urology, neurosurgery, women's health, IVF, and check-up are the leading specialties in Anadolu Hospital.

The medical center is among the Top 10 hospitals in the world according to the Medical Travel Quality Alliance (MTQUA), an international organization that promotes excellent standards of health services for medical tourists.

Patients from the United States, the United Kingdom, Romania, Bulgaria, and Azerbaijan choose Anadolu Medical Center.

Summary about Anadolu from patients' reviews:

The Anadolu Clinic is a highly-regarded medical facility located on the coast of the marble sea. It is renowned for its professionalism, cleanliness, and attention to detail. The staff is polite, attentive, and responsive to patients' needs. Highly-trained and skilled doctors are available for comprehensive examinations and treatments, and the recovery room is bright and comfortable with a beautiful view. Patients have benefited from the services of an excellent translator, Elmira, and the support of coordinators Zakhida, Bakhtygul, and Amina, Gayana. The clinic also offers a transfer service from the airport to the hotel and back, as well as booking a hotel conveniently located 10-15 minutes away. Anadolu is the perfect choice for a successful treatment and recovery.

Top 5 Anadolu Advantages: 

  1. Highly skilled and experienced medical staff 
  2. Advanced equipment 
  3. Personal coordinators and interpreters
  4. Pleasant atmosphere 
  5. Wide range of medical services and treatments
Chemotherapy for Brain Tumor Patient Experience Reviews
Verified review.
All very pleased, pleasures people, experienced doctors, friendly staff, I recommend
— Виктория
Ukraine, Aug 7, 2018
Aug 7, 2018 • Verified review.
Chemotherapy for Brain Tumor $1000 - $3000
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Turkey, Istanbul
83% patients recommend

Read more details Hide details

Hisar Hospital Intercontinental is a multi-specialty medical center in Turkey, Istanbul.

The medical center specializes in pediatric and adult cardiovascular surgery, orthopedics, oncology, weight loss surgery, and check-ups. Hisar Intercontinental Hospital serves only adults. 250,000 patients choose Hisar Intercontinental Hospital to get medical care every year.  Hisar Hospital is certified by JCI (Joint Commission International) that confirms compliance with international standards of treatment quality and safety.

Patients from CIS, Balkans and African countries choose Hisar Hospital for medical care.

Chemotherapy for Brain Tumor Patient Experience Reviews
Verified review.
I was really nervous about a new breast lump that developed. I reached out to Book I med and explained my situation. I was directed to Hisar Intercontinental Hospital. They did biopsy, ultrasound and PET scan. Although I wanted surgery, doctor explained it wasn't in my best interest and recommended medication instead. Doctors were careful to come up with plan, they didn't rush to make decisions. I had a medical coordinator who assisted in transportation to and from hospital and coordinating tests and doctor visits. I was also assigned an interpreter for Turkish to English.They were both wonderful and it was nice to have assistance and smiling faces when I arrived. They always took time to listen to concerns and answer questions. I met with 2 doctors, a breast cancer surgeon and oncologist. They both were professional and friendly. They met with a tumor board of physicians to discuss my plan.I feel like I got professional care and good treatment plan. The hospital was clean and modern. They did a good job with the tests, I didn't feel any pain from the doctor who did my biopsy. Believe me when you have something as scary as a breast lump you want to be in good hands.I paid for each test and medication individually with credit card. I was told the cost before each purchase. Even though the whole bill wasn't cheap, it's much much lower cost than I could get in United States. As a self pay patient I am glad for that also. So overall even though I was struggling with something really bad(tumor) I feel like I got great and professional care at a decent price. I would truly recommend this to anyone. And Turkey is such a beautiful country with friendly people. There is hidden artwork everywhere. So even though I am going through this ordeal being in beautiful Turkey makes it not so bad. The food here is really good and cheap. I'm staying in Old city which has tons of Cafe restaurants. In your spare time just sitting at a Cafe and watching the myriad of people walking by is fun. I am confident I am going to beat this breast tumor with the help of the wonderful care given at Hisar Intercontinental Hospital.
Read more
— Mary Daniels
United Arab Emirates, Jun 15, 2023
Jun 15, 2023 • Verified review.
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Turkey, Istanbul
84% patients recommend

Read more details Hide details

Liv Hospital Ulus is a multi-specialized medical center located in Istanbul.

Orthopedics, cancer treatment, weight loss surgery, neurosurgery, heart surgery and regenerative medicine are the leading specialties in the hospital.

Liv is a smart hospital with innovative medical technologies available: da Vinci robot-assisted system for the surgeries, MAKOplasty for knee replacement, YAG Laser for vascular surgery, virtual angiography for cardiac diagnostics, etc.

Liv Hospital in Istanbul is a popular weight loss surgery clinic in Turkey — patients lose 71% of their excess weight in a year.

Chemotherapy for Brain Tumor Patient Experience Reviews
Verified review.
She sent for PET / CT revision made at the Korean clinic Severance Hospital, because Severance made a very dubious short description, more like an unsubscribing. I chose Liv Hospital, assistant Bookimed Alexei and assistant Liv Hospital Lala all organized perfectly, data exchange by e-mail, payment at a reasonable price, three days and the description is ready, done well, in detail and clearly. Bookimed coordinator Aleksey Karaganov is a very caring and highly qualified specialist who helped with the consultation and discussion of the diagnosis.
Read more
— Александр
Russian Federation, Mar 24, 2020
Mar 24, 2020 • Verified review.
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Turkey, Istanbul
86% patients recommend

Read more details Hide details

Medipol University Hospital is one of the largest multi-specialty medical institution in Turkey. Daily, over 1,200 patients trust their health to Medipol's experts. The hospital is equipped with advanced technologies, i.e, Da Vinci Surgical System, Cyber and Gamma Knives. Doctors specialize in cancer, neurological, and cardiovascular treatment. Organ transplantation, bone marrow transplant and IVF are among key specialties of the hospital.

Chemotherapy for Brain Tumor Patient Experience Reviews
Verified review.
Everything went very well, the attending physician and the medical staff are great fellows and super professionals.
Read more
— Владислав Потруг
Moldova, Sep 10, 2018
Sep 10, 2018 • Verified review.
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Turkey, Istanbul
77% patients recommend

Read more details Hide details

Emsey Hospital, one of Turkey's multi-specialty private medical centers, provides health services at the A+ class level hospital. The hospital has ISO and JCI accreditations as a reliable medical center. The facility offers general, surgical, and internal medicine treatments as a general hospital. Emsey Hospital has provided healthcare services to patients worldwide since 2012. The hospital's Advanced Spine Surgery Center performs congenital and complicated orthopedic treatments, from scoliosis to spine fusion surgeries. The Bone Marrow Transplantation Unit is one of the largest BMT units in Turkey, with 45 beds. 

Chemotherapy for Brain Tumor Patient Experience Reviews
Verified review.
We liked Emsey clinic very much. we were met from the airport with an interpreter and a driver. then placed in a very good hotel. delicious food was served 2 times at the hotel. The hotel had spacious comfortable rooms with all amenities. On the 1st day we were brought for analysis, on the 2nd day they made a diagnosis, started treatment and we were placed in a ward. Within 5 days, we received the necessary treatment and good service. The doctors were very skilled and experienced. The coordinator Janseit was with us for 1 week and was very helpful in creating all the necessary amenities for us. Thanks to all the staff at Emsey Clinic.
Read more
— Дурдона
Uzbekistan, Nov 13, 2021
Nov 13, 2021 • Verified review.
Chemotherapy for Brain Tumor $1200 - $3000
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Turkey, Istanbul
33% patients recommend

Read more details Hide details

Istanbul Oncology Hospital is a private multi-specialty medical center located in Istanbul, Turkey. Istanbul Oncology Hospital, established in 2008, started as an outpatient oncology clinic and later expanded to become a fully-fledged Oncology Hospital in 2015. The team is dedicated to orthopedics, oncology, diagnostics, and medical check-up. Istanbul Oncology Hospital serves only adults. At Istanbul Oncology Hospital, all procedures and medical interventions are carried out by experienced medical staff guided by advanced technology. 11640 patients choose Istanbul Oncology Hospital to get medical care every year. Patients from Russian-speaking countries, Europe & Commonwealth, and the Balkans often visit the clinic.

Chemotherapy for Brain Tumor Patient Experience Reviews
Verified review.
I felt very comfortable and very well cared for. And everybody treated me so well. So much better than in San Francisco. I also liked that I got direct answers to all my questions.
Read more
— Aline
United States of America, Apr 15, 2024
Apr 15, 2024 • Verified review.
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Turkey, Istanbul
100% patients recommend

Read more details Hide details

Dr. Ibrahim Karatas Clinics is a private multi-specialty medical center in Istanbul, Turkey. The team is dedicated to gastroenterology, weight loss surgery, and mammology. According to the clinic’s data, the success rate for gastric sleeve surgery (sleeve gastrectomy) is above 95%. Dr. Ibrahim Karatas Clinics serves only adults. 1,000 patients choose to get medical care at the clinic every year. Patients from Europe, the Commonwealth, the USA, Canada, Australia, and the CIS countries visit Dr. Ibrahim Karatas Clinics most often.

Chemotherapy for Brain Tumor Patient Experience Reviews
Verified review.
My coordinator Marsela, went above and beyond to research the perfect Doctor and accommodate with all of her request for the best Doctor. She always answered my questions and followed up when needed. My surgery coordinators Zeynep and Hisham were amazing and followed up and Hisham was there in person from the pre-op to post op and both were there 24 hours a day when I needed them or just to make sure I was doing good following my surgery. Dr. Emre Ozenalp is a very skilled surgeon and is amazing. The cuts he made I will have little scarring due to being a skilled surgeon. Dr. Emre and his Nurses followed up everyday to check on my status. He’s Nurses are amazing and we’re very compassionate since I am a very modest person. I would highly recommend Bookimed, my surgery coordinators, and Dr. Emre and his Nurses. I am very amazed and super excited about my outcome of my surgery. My amazing husband who was by my side the whole and supported my decision was absolutely amazed and thanked Dr. Emre for the amazing work he did on my tummy tuck. I now have a flat tummy and no stretch’s marks. 💕
Read more
— Raquell Stringfellow
United States of America, Apr 29, 2024
Apr 29, 2024 • Verified review.
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes
Turkey, Istanbul
71% patients recommend

Read more details Hide details

Chemotherapy for Brain Tumor Patient Experience Reviews
Verified review.
Everything went well! I liked the clinic!
— Дмитрий
Ukraine, Jan 22, 2022
Jan 22, 2022 • Verified review.
Submit a free request
Ask us any question you might have
We’ll respond in 5 minutes

Your Medical Travel Guide: Essential Tips and Advice

question
explanation
How many days do I need to stay in Turkey?
7 days
How much extra money do I need (additional to the procedure)?
A night in a 5-star hotel on full board basis — $100. A night in a 4-star hotel breakfast included — $50. A night in a 3-star hotel breakfast included — $30. Lunch & dinner — $15.
Some clinics include 4- or 5-star hotel stay in the procedure cost.
Do I need a visa?
For citizens of the UK: visa is not required. For citizens of the USA: online visa is available — $76.50.
For citizens of other countries — please visit ivisa.com to find more details on entry requirements to Turkey.
What payment options are available?
PayPal, cash, credit cards (Visa, MasterCard).
Transfers
Flight tickets to Turkey: are not included in the price.
Transfer: most of clinics provide a free airport-clinic-airport transfer for patients coming for the procedure.

Get a Medical Assessment for Chemotherapy for Brain Tumor in Turkey: Select Your Expert from 4 Experienced Doctors

Turkey, Istanbul
Mustafa Solak
Clinical oncologist
18 years of experience
Hisar Intercontinental Hospital
Mustafa Solak, M.D., who was born in 1978, was graduated from School of Medicine, Hacettepe University. He completed his residency education in İstanbul Sisli Etfal Teaching and Research Hospital and completed his fellowship in Cancer Institute of Hacettepe University.   He has dealt with many cases of Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, Gastrointestinal Cancers.   FIELDS OF MEDICAL INTEREST Breast cancer Testicular Cancer Ovarian Cancer Lung Cancer Head & Neck Cancers Gastrointestinal cancers EDUCATİON: Bachelor's: Hacettepe University Faculty of Medicine Specialization: Istanbul Sisli Etfal Training and Research Hospital Minor Specialization: Hacettepe University Cancer Institute INSTITUTIONS WHERE EDUCATION AND WORKED The University of Texas MD Anderson Cancer Center Hitit University Corum Training Hospital Medical Park Hospital
Turkey, Istanbul
Sezer Saglam
Clinical oncologist
27 years of experience
Group Florence Nightingale Hospitals
Professional Experience Gayrettepe Florence Nigthingale Hospital Medical Oncology Department Besiktas/Istanbul/Turkey (ongoing)   Education: He became Professor (22/April /2016) Medical Oncology   Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009) Istanbul University Oncology Institue, Department of Medical Oncology   Medical Oncology Fellowship (December 2001-December2004) Istanbul University, Istanbul Medical Faculty   Hemodialysis Traning (May1996-January1997) Istanbul University ,bCerrahpasa Medical Faculty   Internal Medicine Residency (November 1991-November 1996) Istanbul University ,bCerrahpasa Medical Faculty   Ege University Medical Faculty (1985-1991)   Professional Experience   February 1999-November 2001 Metropolitan Florence Nigthingale Hospital American Cancer Center, Gayrettepe/İstanbul   April1997- October 1998 Bayraktar Dialysis Center Güngören/ Istanbul   Membership   Turkish Medical Oncology Association ENET(European Neuroendocrine Tumour Society) ESMO ASCO
Turkey, Istanbul
Nail Paksoy
Oncologist/mammologist
13 years of experience
Medipol Bahçelievler Hospital
PROFESSIONAL EXPERIENCE2011-2012Erzurum Koprukoyu State HospitalDepartment: General Medicine2012-2017Istanbul University Cerrahpaşa Medical FacultyDepartment: Internal Medicine06/2017-10/2017Istanbul Gaziosmanpasa Taksim Training and Research HospitalDepartment: Internal Medicine10/2017-11/2018Istanbul University Istanbul Medical FacultyDepartment: Allergy and Immunology Fellowship2018/2022Istanbul University Oncology InstituteDepartment: Medical Oncology Fellowship2022-2023Tekirdag City HospitalDepartment: Medical Oncology Specialist2023-presentIstanbul Medipol University Medipol Bahcelievler Private HospitalDepartment: Medical Oncology Assoc. Prof. EDUCATION2005-2011Medical EducationSivas Cumhuriyet University Medical Faculty, Sivas, Turkey2012-2017Internal MedicineIstanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey2017-2018Allergy-Immunology FellowshipIstanbul University Istanbul Medical FacultyDepartment of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey2018-2022Medical Oncology FellowshipIstanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey2022ESMO Board Certification in Medical Oncology10th September 2022 in Paris, France.2023Medical Oncology Assoc. Prof.Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey INTERNATIONAL CLINICAL TRIALS:1. Astefania - ROCHETitle: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative TherapyRole: Subinvestigator2. PFİZERTitle: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLCRole: Subinvestigator3. RECITE - AMGENTitle: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerRole: Subinvestigator4. NAVIGATE - BAYERTitle: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsRole: Subinvestigator5. RUBY - Tesaro (PRA)Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial CancerRole: Subinvestigator6. ENGOT-ov43/GOG-3036 - MSDTitle: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)Role: Subinvestigator7. ASTRA ZENECATitle: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.Role: Subinvestigator8. ROSY-O - ASTRA ZENECATitle: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibRole: Subinvestigator INTERNATIONAL PUBLICATIONSI. Published journal articles indexed by SCI, SSCI, and AHCIWeekly Paclitaxel in Classic Kaposi SarcomaAuthors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.Journal: Medicine, 102(5)Carboplatin Desensitization in Ovarian CarcinomaAuthors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.Journal: Medicine, 101(45), e31726High-Dose Chemotherapy for Ewing’s SarcomaAuthors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.Journal: Medicine, 101(49), e32213Multidrug Refractory TFE3(+) Renal Cell CarcinomaAuthors: Paksoy, Nail, et al.Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221Crizotinib Efficacy in NSCLC with MET AlterationsAuthors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.Journal: Medicine, 101(50), e32368Clinicopathological Features in ALK Mutant NSCLCAuthors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.Journal: Medicine, 101(34)PSMA-Based Tumor Burden in Prostate CancerAuthors: HAS SIMSEK, Duygu, et al.Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690Atezolizumab in Metastatic Urothelial CarcinomaAuthors: TURAL, Deniz, et al.Journal: European Urology Focus, 2021, 7.5: 1061-1066Pulmonary Sarcomatoid CarcinomaAuthors: FERHATOGLU, Ferhat, et al.Journal: Oncology Research and Treatment, 2021, 44.11: 590-601Prognostic Factors in Atezolizumab-Treated Urothelial CarcinomaAuthors: TURAL, Deniz, et al.Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513Atezolizumab with Chemotherapy in Small Cell Lung CancerAuthors: GÜRBÜZ, Mustafa, et al.Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic CancerAuthors: AY, Seval, et al.Journal: Journal of Chemotherapy, 2022, 1-7Trastuzumab Emtansine in Older HER2-Positive Breast Cancer PatientsAuthors: CIL, Ibrahim, et al.Journal: Tumori Journal, 2022, 108.1: 19-25Real-Life Efficacy of Osimertinib in Advanced NSCLCAuthors: HIZAL, Mutlu, et al.Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508ALK-Positive Cells Percentage and Alectinib EfficacyAuthors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148Real-World Data on Alectinib in ALK-Positive NSCLCAuthors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.Journal: Future Oncology, 18(23), 2573-2582Prognostic Factors in Metastatic RCC with T790M MutationAuthors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsFLOT Regimen in Metastatic Gastric CancerAuthors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.Journal: Journal of Cancer Research and TherapeuticsDesensitization Protocol in Lenalidomide Hypersensitivity ReactionsAuthors: DEMIR, Semra, et al.Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397Factors Associated with Diagnostic Skin Test Positivity in PPI HypersensitivityAuthors: ÖZDEMIR, Seçil Kepil, et al.Journal: Allergy, 2019, 74.6: 1187-1190Efficacy of Capecitabine and Temozolomide in Neuroendocrine TumorsAuthors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.Journal: The Oncologist, oyad257Subsequent Treatments in Hormone-Positive Breast Cancer ProgressionAuthors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.Journal: BMC cancer, 23(1), 192Termination of Trastuzumab in HER2-Positive Metastatic Breast CancerAuthors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.Journal: Scientific Reports, 13(1), 8779Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast CancerAuthors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.Journal: Journal of Cancer Research and Clinical Oncology, 1-9Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast CancerAuthors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.Journal: European Journal of Breast Health, 19(2), 128Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast CancerAuthors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.Journal: Future Oncology, 19(10), 727-736Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma PatientsAuthors: Dogan, I., Paksoy, N., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsSingle-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma PatientsAuthors: Dogan, I., Paksoy, N., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsOutcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain MetastasesAuthors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.Journal: Journal of Cancer Research and TherapeuticsFLOT Regimen in First-Line Treatment of Metastatic Gastric CancerAuthors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.Journal: Journal of Cancer Research and TherapeuticsPrognostic Factors of Perioperative FLOT Regimen in Operable Gastric CancerAuthors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.Journal: [Not specified]Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi SarcomaAuthors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.Journal: Medicine, 102(39), e35383Comparison of Second-Line Treatments in Metastatic Renal Cell CarcinomaAuthors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.Journal: Medicine, 102(41), e35245Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGYPredictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of PulmonologyLaterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye Thesis:Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combinationAuthors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group studyAuthors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancerAuthors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)Efficacy of temozolomide in pretreated patients with metastatic sarcomaAuthors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumorsAuthors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcomaAuthors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastasesAuthors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinomaAuthors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk studyAuthors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiencesAuthors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)  
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Bookimed editorial policy

Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Chemotherapy for Brain Tumor by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Chemotherapy for Brain Tumor, crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission here.

Chemotherapy for Brain Tumor Bookimed Medical Advisory Board expert

Doctor Yesim Yildirim is an oncologist certified by the European Society of Medical Oncology (ESMO). Affiliated with numerous hospitals in the United States and Turkey, including the University of Maryland Medical Center, Johns Hopkins Hospital and Memorial Sisli Hospital. She has over 20 years of experience and has a special interest in preventive medicine, diabetes, and hypertension. Holds an MBA in Healthcare Management and shares her expertise with Bookimed from 2022.

The Medical Advisory Board expert is a verified credible medical professional with solid theoretical background and practical experience in the field. The expert provides support related to medical content accuracy for medical writers and performs educational workshops to Bookimed coordinators serving patient requests.

The medical content creation under the expert’s control follows rigorous and well-established procedure to be informative, trustworthy, and transparent and making Bookimed.com a credible source of evidence-based health information.